BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao Y, Yang L, He J, Yang H. STYK1 promotes Warburg effect through PI3K/AKT signaling and predicts a poor prognosis in nasopharyngeal carcinoma. Tumour Biol 2017;39:1010428317711644. [PMID: 28720063 DOI: 10.1177/1010428317711644] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Wen L, Ding Y, Chen X, Tian K, Li D, Liang K, Yue B. Influences of S100A8 and S100A9 on Proliferation of Nasopharyngeal Carcinoma Cells through PI3K/Akt Signaling Pathway. Biomed Res Int 2021;2021:9917365. [PMID: 34604387 DOI: 10.1155/2021/9917365] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Lai Y, Lin F, Wang X, Zhang J, Xia J, Sun Y, Wen M, Li X, Zhang Z, Zhao J. STYK1/NOK Promotes Metastasis and Epithelial-Mesenchymal Transition in Non-small Cell Lung Cancer by Suppressing FoxO1 Signaling. Front Cell Dev Biol 2021;9:621147. [PMID: 34295886 DOI: 10.3389/fcell.2021.621147] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Zhang J, Zhou J, Xiao S. Shikonin inhibits growth, invasion and glycolysis of nasopharyngeal carcinoma cells through inactivating the phosphatidylinositol 3 kinase/AKT signal pathway. Anticancer Drugs 2020;31:932-41. [PMID: 32282369 DOI: 10.1097/CAD.0000000000000920] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
4 Zhao P, Zhou M, Chen R, Su R. Suppressed "Warburg Effect" in Nasopharyngeal Carcinoma Via the Inhibition of Pyruvate Kinase Type M2-Mediated Energy Generation Pathway. Technol Cancer Res Treat 2020;19:1533033820945804. [PMID: 32815467 DOI: 10.1177/1533033820945804] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Long W, Gong X, Yang Y, Yang K. Downregulation of PER2 Promotes Tumor Progression by Enhancing Glycolysis via the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway in Oral Squamous Cell Carcinoma. J Oral Maxillofac Surg 2020;78:1780.e1-1780.e14. [PMID: 32615095 DOI: 10.1016/j.joms.2020.05.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Zhou L, Li S, Liu L, Zhou Q, Yuan Y, Xin L. [Recombinant methioninase regulates PI3K/Akt/Glut-1 pathway and inhibits aerobic glycolysis to promote apoptosis of gastric cancer cells]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:27-33. [PMID: 32376548 DOI: 10.12122/j.issn.1673-4254.2020.01.05] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Li X, Yu W, Liang C, Xu Y, Zhang M, Ding X, Cai X. INHBA is a prognostic predictor for patients with colon adenocarcinoma. BMC Cancer 2020;20:305. [PMID: 32293338 DOI: 10.1186/s12885-020-06743-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
8 Fauteux-Daniel S, Faure F, Marotel M, Geary C, Daussy C, Sun JC, Walzer T. Styk1 expression is a hallmark of murine NK cells and other NK1.1+ subsets but is dispensable for NK-cell development and effector functions. Eur J Immunol 2019;49:677-85. [PMID: 30690705 DOI: 10.1002/eji.201847721] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Fang J, Wang H, Fang X, Li N, Hu H, Bian M, Yang P. Low STYK1 expression indicates poor prognosis in gastric cancer. Cancer Manag Res 2018;10:6669-76. [PMID: 30584361 DOI: 10.2147/CMAR.S181910] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
10 Noble PA, Pozhitkov AE. Cryptic sequence features in the active postmortem transcriptome. BMC Genomics 2018;19:675. [PMID: 30217147 DOI: 10.1186/s12864-018-5042-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Abdel-Hafiz HA, Dudevoir ML, Perez D, Abdel-Hafiz M, Horwitz KB. SUMOylation Regulates Transcription by the Progesterone Receptor A Isoform in a Target Gene Selective Manner. Diseases 2018;6:E5. [PMID: 29301281 DOI: 10.3390/diseases6010005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Chen L, Ma C, Bian Y, Shao C, Wang T, Li J, Chong X, Su L, Lu J. Aberrant expression of STYK1 and E-cadherin confer a poor prognosis for pancreatic cancer patients. Oncotarget 2017;8:111333-45. [PMID: 29340057 DOI: 10.18632/oncotarget.22794] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]